Citation Impact

Citing Papers

Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies
2008 Standout
Global increase and geographic convergence in antibiotic consumption between 2000 and 2015
2018 Standout
Generation of knock-in primary human T cells using Cas9 ribonucleoproteins
2015 StandoutNobel
High Coverage of ART Associated with Decline in Risk of HIV Acquisition in Rural KwaZulu-Natal, South Africa
2013 StandoutScience
CD4+ Count–Guided Interruption of Antiretroviral Treatment
2006 Standout
Incidence of Myocardial Infarction in Randomized Clinical Trials of Protease Inhibitor-Based Antiretroviral Therapy: An Analysis of Four Different Protease Inhibitors
2003
Re-epithelialization and immune cell behaviour in an ex vivo human skin model
2020 Standout
X4 and R5 HIV-1 Have Distinct Post-entry Requirements for Uracil DNA Glycosylase during Infection of Primary Cells
2010 StandoutNobel
The deltaccr5 mutation conferring protection against HIV-1 in Caucasian populations has a single and recent origin in Northeastern Europe
1998
Chemotactic activity on mononuclear cells in the cerebrospinal fluid of patients with viral meningitis is mediated by interferon‐γ inducible protein‐10 and monocyte chemotactic protein‐1
1997
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
2010 Standout
Clinical Features and Contribution of Virological Findings to the Management of Kaposi Sarcoma in Organ-Allograft Recipients
2000
Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV
2014
Toll‐Like Receptor 2–Deficient Mice Are Highly Susceptible toStreptococcus pneumoniaeMeningitis because of Reduced Bacterial Clearing and Enhanced Inflammation
2002
Treatment of Pulmonary Arterial Hypertension
2004 Standout
Chemokines — Chemotactic Cytokines That Mediate Inflammation
1998 Standout
Decreased HIV Transmission after a Policy of Providing Free Access to Highly Active Antiretroviral Therapy in Taiwan
2004
Natural history of HIV infection in the_era of combination antiretroviral therapy
1999
The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
2004 Standout
Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: a randomized clinical trial
2010 StandoutNobel
Target preference of Type III-A CRISPR-Cas complexes at the transcription bubble
2019 StandoutNobel
Origins and Mechanisms of miRNAs and siRNAs
2009 Standout
Long-Term HIV/AIDS Survival Estimation in the Highly Active Antiretroviral Therapy Era
2003
Staphylococcus aureus bloodstream infection: A pooled analysis of five prospective, observational studies
2013
Clinical Characteristics and Risk Factors for Mortality in Patients with Meningitis Caused by Staphylococcus aureus and Vancomycin Minimal Inhibitory Concentrations Against These Isolates
2010
Increasing incidence of pyogenic spondylodiscitis: A 14-year population-based study
2013
Cytokines in asthma
1999
Epitope Mapping of CCR5 Reveals Multiple Conformational States and Distinct but Overlapping Structures Involved in Chemokine and Coreceptor Function
1999
Mortality of S. aureus bacteremia and infectious diseases specialist consultation – A study of 521 patients in Germany
2009
Severe Sepsis and Septic Shock
2013 Standout
Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression
1998
Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patients
2010
Skin Cancers after Organ Transplantation
2003 Standout
Structural Basis for the Resilience of Efavirenz (DMP-266) to Drug Resistance Mutations in HIV-1 Reverse Transcriptase
2000
Review of the Molecular and Cellular Mechanisms of Action of Glucocorticoids for Use in Asthma
2002
Missing Pieces in the NF-κB Puzzle
2002 Standout
Portal hypertensive bleeding in cirrhosis
2016 Standout
Access to effective antimicrobials: a worldwide challenge
2015
Staphylococcus aureus Meningitis
2010
Trans-splicing in C. elegans generates the negative RNAi regulator ERI-6/7
2008 StandoutNatureNobel
Cardiovascular and Cerebrovascular Events in Patients Treated for Human Immunodeficiency Virus Infection
2003
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
2020 Standout
Prophylaxis against Opportunistic Infections in Patients with Human Immunodeficiency Virus Infection
2000
Staphylococcus aureus bacteraemia in Iceland, 1995–2008: changing incidence and mortality
2010
Methicillin-Resistant Staphylococcus aureus Meningitis in Adults
2011
Host Genes and HIV: The Role of the Chemokine Receptor Gene CCR5 and Its Allele (∆32 CCR5)
1997
Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia
2011
Host factors in the pathogenesis of HIV disease
1997
The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression
1997
Asthma
2001 Standout
A Membrane-proximal Basic Domain and Cysteine Cluster in the C-terminal Tail of CCR5 Constitute a Bipartite Motif Critical for Cell Surface Expression
2001 StandoutNobel
Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections
2015
Staphylococcus aureus Bacteraemia in a Tropical Setting: Patient Outcome and Impact of Antibiotic Resistance
2009
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
Development and Applications of CRISPR-Cas9 for Genome Engineering
2014 Standout
Genetic predisposition to respiratory infection and sepsis
2011
Phenylethylthiazolylthiourea (PETT) Non-nucleoside Inhibitors of HIV-1 and HIV-2 Reverse Transcriptases
2000
Prevalence of infective endocarditis in patients with Staphylococcus aureus bacteraemia: the value of screening with echocardiography
2011
Factors Predicting and Reducing Mortality in Patients with Invasive Staphylococcus aureus Disease in a Developing Country
2009
AIDS across Europe, 1994–98: the EuroSIDA study
2000
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 Standout
The changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance study
2012
Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients
1999
Revealing the world of RNA interference
2004 StandoutNatureNobel
Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study
2005
Functional Proteomics Reveals the Biochemical Niche of C. elegans DCR-1 in Multiple Small-RNA-Mediated Pathways
2006 StandoutNobel
The CD4 lymphocyte count and risk of clinical progression
2006
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
2004 Standout
Infection in Solid-Organ Transplant Recipients
2007 Standout
Staphylococcus aureusBloodstream Infections: Risk Factors, Outcomes, and the Influence of Methicillin Resistance in Calgary, Canada, 2000–2006
2008
A 20-year retrospective review of global aquaculture
2021 StandoutNature
Serious Fatal and Nonfatal Non-AIDS-Defining Illnesses in Europe
2010
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies
2002
Telephone Consultation Cannot Replace Bedside Infectious Disease Consultation in the Management of Staphylococcus aureus Bacteremia
2012
Causes of death among HIV‐infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998–1999
2002
Steady‐State Pharmacokinetics of Emtricitabine and Tenofovir Disoproxil Fumarate Administered Alone and in Combination in Healthy Volunteers
2007
Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study
2015 Standout
Stem cell-derived polarized hepatocytes
2020 StandoutNobel
Pathogen Recognition and Innate Immunity
2006 Standout
Guidelines for Using Antiretroviral Agents among HIV-Infected Adults and Adolescents: The Panel on Clinical Practices for Treatment of HIV*
2002
Binding of the Second Generation Non-nucleoside Inhibitor S-1153 to HIV-1 Reverse Transcriptase Involves Extensive Main Chain Hydrogen Bonding
2000
Efavirenz
2001
The Many Roles of Chemokines and Chemokine Receptors in Inflammation
2006 Standout
Development and validation of a prognostic model for survival time data: application to prognosis of HIV positive patients treated with antiretroviral therapy
2004
Prognostic Factors for Survival in Human Immunodeficiency Virus–associated Pulmonary Arterial Hypertension
2003
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Early protective effect of CCR-5 Δ32 heterozygosity on HIV-1 disease progression
1997
Fluorine in medicinal chemistry
2007 Standout
Combination Antiretroviral Therapy and the Risk of Myocardial Infarction
2003 Standout
Glucocorticoid Receptor Recruitment of Histone Deacetylase 2 Inhibits Interleukin-1β-Induced Histone H4 Acetylation on Lysines 8 and 12
2000
Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages
1999 StandoutNobel
Prevention of Infection Due toPneumocystisspp. in Human Immunodeficiency Virus-Negative Immunocompromised Patients
2004
Bioactive compounds in seaweed: functional food applications and legislation
2011 Standout
Glucocorticoids in T Cell Development and Function
2000
Staphylococcus aureus bloodstream infections in children: A population-based assessment
2011
Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand
2009
Possible influence of the mutant CCR5 allele on vertical transmission of HIV-1
1998
HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis
2006
Chimeric Antigen Receptor Therapy
2018 Standout
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Micromanaging insulin secretion
2004 StandoutNobel
Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study
2003
CHEMOKINE RECEPTORS AS HIV-1 CORECEPTORS: Roles in Viral Entry, Tropism, and Disease
1999 Standout
Clinical Outcome of Patients with HIV-1 Infection according to Immunologic and Virologic Response after 6 Months of Highly Active Antiretroviral Therapy
2000
CRISPR/Cas, the Immune System of Bacteria and Archaea
2010 StandoutScience
Predictors of Mortality in Staphylococcus aureus Bacteremia
2012
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
2015 Standout
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries
2006
Structure of HIV-1 reverse transcriptase bound to an inhibitor active against mutant reverse transcriptases resistant to other nonnucleoside inhibitors
2004 StandoutNobel
Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies
2003
Latent reservoirs of HIV: Obstacles to the eradication of virus
1999
Normal development is an integral part of tumorigenesis in T cell-specific PTEN-deficient mice
2008 StandoutNobel
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
CXCR4 and CCR5 Genetic Polymorphisms in Long-Term Nonprogressive Human Immunodeficiency Virus Infection: Lack of Association with Mutations other than CCR5-Δ32
1998
Exclusive and Persistent Use of the Entry Coreceptor CXCR4 by Human Immunodeficiency Virus Type 1 from a Subject Homozygous for CCR5 Δ32
1998
Design of MKC-442 (Emivirine) Analogues with Improved Activity Against Drug-Resistant HIV Mutants
1999

Works of Thomas Benfield being referenced

Effect of propranolol on survival in patients with decompensated cirrhosis: a nationwide study based Danish patient registers
2016
Common TNF-α, IL-1β, PAI-1, uPA, CD14 and TLR4 polymorphisms are not associated with disease severity or outcome from Gram negative sepsis
2007
Stable incidence and continued improvement in short term mortality of Staphylococcus aureus bacteraemia between 1995 and 2008
2012
Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome
2006
Human Herpes Virus-8 DNA in Bronchoalveolar Lavage Samples from Patients with AIDS-associated Pulmonary Kaposi's Sarcoma
1997
Changing patterns of mortality across Europe in patients infected with HIV-1
1998
Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals
1997
COPD Stage and Risk of Hospitalization for Infectious Disease*
2008
Major but differential decline in the incidence of Staphylococcus aureus bacteraemia in HIV‐infected individuals from 1995 to 2007: a nationwide cohort study*
2011
Corticosteroids induce intracellular interleukin-1 receptor antagonist type I expression by a human airway epithelial cell line.
1996
Changing Epidemiology of Pediatric Staphylococcus aureus Bacteremia in Denmark From 1971 Through 2000
2007
Chemokine Receptor CCR2b 64I Polymorphism and Its Relation to CD4 T-Cell Counts and Disease Progression in a Danish Cohort of HIV-Infected Individuals
1998
HIV-Infected Individuals With the CCR5Δ32/CCR5 Genotype Have Lower HIV RNA Levels and Higher CD4 Cell Counts in the Early Years of the Infection Than Do Patients With the Wild Type
1997
Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P carinii pneumonia
1999
Haematogenous Staphylococcus aureus meningitis. A 10-year nationwide study of 96 consecutive cases
2006
A Suction Blister Protocol to Study Human T-cell Recall Responses <em>In Vivo</em>
2018
Impact of 13-Valent Pneumococcal Conjugate Vaccination in Invasive Pneumococcal Disease Incidence and Mortality
2014
Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000
2006
Regional Differences in Use of Antiretroviral Agents and Primary Prophylaxis in 3122 European HIV-Infected Patients
1997
Interleukin-8 in cerebrospinal fluid from patients with septic and aseptic meningitis
1996
Changes in biomarkers of cardiovascular risk after a switch to abacavir in HIV‐1‐infected individuals receiving combination antiretroviral therapy
2009
Treatment with a monoclonal antibody to IL-8 attenuates the pleocytosis in experimental pneumococcal meningitis in rabbits when given intravenously, but not intracisternally
2000
Inhibition of Leukocyte Entry into the Brain by the Selectin Blocker Fucoidin Decreases Interleukin-1 (IL-1) Levels but Increases IL-8 Levels in Cerebrospinal Fluid during Experimental Pneumococcal Meningitis in Rabbits
2000
Rankless by CCL
2026